{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:11:14Z","timestamp":1778155874574,"version":"3.51.4"},"reference-count":26,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Prostate-specific antigen (PSA) remains the primary biomarker for prostate cancer detection; however, its limited specificity leads to unnecessary biopsies. Systemic inflammatory indices derived from routine blood tests have been proposed as potential adjunctive diagnostic tools. This study aimed to evaluate the diagnostic performance of these indices in patients undergoing prostate biopsy for suspected prostate cancer. Methods: A retrospective observational study was conducted, including 307 patients who underwent transrectal ultrasound-guided prostate biopsy for elevated PSA between January 2021 and January 2023. Patients were classified as benign prostatic hyperplasia (BPH) or prostate cancer (PCa) based on histopathological findings. Inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), systemic immune\u2013inflammation index (SII), Systemic Inflammation Response Index (SIRI), and aggregate index of systemic inflammation (AISI), were calculated. Logistic regression and receiver operating characteristic (ROC) analyses were performed to assess diagnostic performance. Results: PCa was diagnosed in 65.1% of patients. Several inflammatory indices were significantly higher in the PCa group. Among them, AISI showed diagnostic performance comparable to PSA. The integration of inflammatory indices into multivariable models improved predictive accuracy, with the combined model demonstrating the highest discriminative ability. In contrast, these markers showed limited capacity in distinguishing tumour aggressiveness. Conclusions: Systemic inflammatory indices are associated with prostate cancer presence and may enhance diagnostic performance when used alongside PSA. However, their role remains complementary, as they provide limited value in risk stratification and should not be considered standalone diagnostic tools.<\/jats:p>","DOI":"10.3390\/medsci14020243","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:39:47Z","timestamp":1778150387000},"page":"243","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond PSA\u2014Can Systemic Inflammatory Indices Improve Prostate Cancer Detection?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-9131","authenticated-orcid":false,"given":"Marius","family":"Iv\u0103nu\u021b\u0103","sequence":"first","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"},{"name":"Department of Urology, \u201cDr. C.I. Parhon\u201d Clinical Hospital, 700503 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2196-1327","authenticated-orcid":false,"given":"Abdallah","family":"Shurrab","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-1251","authenticated-orcid":false,"given":"Drago\u0219","family":"Puia","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"},{"name":"Department of Urology, \u201cDr. C.I. Parhon\u201d Clinical Hospital, 700503 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Maria","family":"Iv\u0103nu\u021b\u0103","sequence":"additional","affiliation":[{"name":"Emergency Care Department, \u201cSf. Spiridon\u201d County University Emergency Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6083-7822","authenticated-orcid":false,"given":"Mihaela","family":"Corlade-Andrei","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"},{"name":"Emergency Care Department, \u201cSf. Spiridon\u201d County University Emergency Hospital, 700111 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolae","family":"Stoican","sequence":"additional","affiliation":[{"name":"Department of Urology, \u201cSf. Ioan cel Nou\u201d County Emergency Hospital, 720033 Suceava, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u0103t\u0103lin","family":"Pricop","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania"},{"name":"Department of Urology, \u201cDr. C.I. Parhon\u201d Clinical Hospital, 700503 Iasi, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Elmadani, M., Mokaya, P.O., Omer, A.A.A., Kiptulon, E.K., Klara, S., and Orsolya, M. (2025). Cancer Burden in Europe: A Systematic Analysis of the GLOBOCAN Database (2022). BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13862-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u20142024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S. (2022). Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.adcanc.2022.100059","article-title":"Understanding of PSA Biology, Factors Affecting PSA Detection, Challenges, Various Biomarkers, Methods, and Future Perspective of Prostate Cancer Detection and Diagnosis","volume":"5","author":"Khan","year":"2022","journal-title":"Adv. Cancer Biol. Metastasis"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Oh, C., and Kang, H. (2025). The Effectiveness and Harms of PSA-Based Prostate Cancer Screening: A Systematic Review. Healthcare, 13.","DOI":"10.3390\/healthcare13121381"},{"key":"ref_6","unstructured":"(2025, December 13). Cancer Research UK. Available online: https:\/\/www.cancerresearchuk.org\/health-professional\/diagnosis\/investigations\/psa-testing."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Heshmat-Ghahdarijani, K., Sarmadi, V., Heidari, A., Falahati Marvasti, A., Neshat, S., and Raeisi, S. (2023). The Neutrophil-to-Lymphocyte Ratio as a New Prognostic Factor in Cancers: A Narrative Review. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1228076"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.20892\/j.issn.2095-3941.2025.0149","article-title":"The Immune Landscape of Systemic Inflammation in Prostate Cancer","volume":"22","author":"Zhang","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ma, L., Yang, F., Guo, W., Tang, S., and Ling, Y. (2024). Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients with Rectal Cancer Undergoing Resection: A Systematic Review and Meta-Analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1415443"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gendis.2021.09.006","article-title":"Inflammation and Cancer: Paradoxical Roles in Tumorigenesis and Implications in Immunotherapies","volume":"10","author":"Liu","year":"2023","journal-title":"Genes. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4103\/jcrt.JCRT_1762_20","article-title":"Prognostic Value of Diffuse Cancer Inflammation Index (ALI), Serum Neutrophil\/Lymphocyte (NLR) and Platelet\/Lymphocyte (PLR) in Advanced-Stage Lung Cancer","volume":"20","author":"Ozturk","year":"2024","journal-title":"J. Cancer Res. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/JIR.S496703","article-title":"The Clinical Value of the Combined Detection of Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Prognostic Nutritional Index (PNI) in Early Diagnosis of Gastric Cancer","volume":"18","author":"Zheng","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","article-title":"Unraveling the Clinical Significance and Prognostic Value of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Delta Neutrophil Index","volume":"24","author":"Islam","year":"2024","journal-title":"Turk. J. Emerg. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12935-019-0785-2","article-title":"Prognostic Significance of Elevated Pretreatment Systemic Inflammatory Markers for Patients with Prostate Cancer: A Meta-Analysis","volume":"19","author":"Peng","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Puia, D., Iv\u0103nu\u021b\u0103, M., and Pricop, C. (2025). DNA methylation in bladder cancer: Diagnostic and therapeutic perspectives\u2014A narrative review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157507"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Oseni, S.O., Naar, C., Pavlovi\u0107, M., Asghar, W., Hartmann, J.X., Fields, G.B., Esiobu, N., and Kumi-Diaka, J. (2023). The molecular basis and clinical consequences of chronic inflammation in prostatic diseases: Prostatitis, benign prostatic hyperplasia, and prostate cancer. Cancers, 15.","DOI":"10.3390\/cancers15123110"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/annonc\/mdu587","article-title":"Baseline neutrophil\u2013lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use","volume":"26","author":"Lorente","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Puia, D., Iv\u0103nu\u021b\u0103, M., and Pricop, C. (2025). Kidney Injury Molecule-1 as a Biomarker for Renal Cancer: Current Insights and Future Perspectives-A Narrative Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073431"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/CBM-150458","article-title":"Benign prostatic hyperplasia and prostate cancer differentiation via platelet-to-lymphocyte ratio","volume":"15","author":"Kaynar","year":"2015","journal-title":"Cancer Biomark."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Puia, D., Iv\u0103nu\u021b\u0103, M., Cauni, V.M., Corlade-Andrei, M., and Pricop, C. (2025). Complete Blood Count-Derived Inflammatory Markers and C-Reactive Protein in Testicular Cancer: Diagnostic and Prognostic Utility. Med. Sci., 13.","DOI":"10.3390\/medsci13040274"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32169","DOI":"10.18632\/oncotarget.5081","article-title":"Neutrophil-to-Lymphocyte Ratio Predicts Prostatic Carcinoma in Men Undergoing Needle Biopsy","volume":"6","author":"Kawahara","year":"2015","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4274\/jus.galenos.2020.3210","article-title":"Predictive Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Measured Prior to Prostate Biopsy","volume":"7","author":"Eren","year":"2020","journal-title":"J. Urol. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wang, S., Ji, Y., Chen, Y., Du, P., Cao, Y., Yang, X., Ma, J., Yu, Z., and Yang, Y. (2022). The Values of Systemic Immune-Inflammation Index and Neutrophil\u2013Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.812319"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.33719\/yud.2021;16-2-794684","article-title":"An Inflammatory Marker for Predicting Prostate Cancer in Prostate Biopsy: Monocyte-to-Lymphocyte Ratio","volume":"16","author":"Demirkol","year":"2021","journal-title":"Yeni Urol. Derg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2025.05.038","article-title":"Magnetic resonance imaging-based biopsy strategies in prostate cancer screening: A systematic review","volume":"88","author":"Schoots","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1007\/s00330-025-12244-2","article-title":"Efficacy endpoints of MRI-based prostate cancer screening: An epidemiological perspective","volume":"36","author":"Bratt","year":"2026","journal-title":"Eur. Radiol."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/243\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:21:16Z","timestamp":1778152876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medsci14020243"],"URL":"https:\/\/doi.org\/10.3390\/medsci14020243","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]}}}